NEW YORK, Sept. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits have been initiated on behalf of shareholders of Missfresh Limited (NASDAQ: MF), Molecular Partners AG (NASDAQ: MOLN), TG Therapeutics, Inc. (NASDAQ: TGTX) and 17 Education and Technology Group, Inc. (NASDAQ: YQ). Shareholders have until the deadlines below to petition the court to appear as lead plaintiffs. For more information on each case, see the link provided.
Missfresh Limited (NASDAQ:MF)
Class Period: As per the Company’s IPO on June 25, 2021
Lead Plaintiff Deadline: September 12, 2022
Missfresh claims to be an innovator and leader in China’s convenience retail sector, having invented the Distributed Mini Warehouse (DMW) model to operate an integrated online and offline on-demand retail business focused on offering fresh produce and fast moving consumer goods (FMCGs).
On or about June 8, 2021, Missfresh filed a registration statement on Form F-1 with the SEC, which would be filed in combination with a subsequent amendment to Form F-1/A and pursuant to Rule 424(b)(4) for the IPO are used.
On June 23, 2021, Missfresh filed with the SEC its final prospectus for the initial public offering on Form 424B4 (the “Prospectus”), which is part of the registration statement. At the IPO, Missfresh sold approximately 21 million American Depositary Shares (“ADSs”) at $13.00 per ADS.
On April 29, 2022, after the close of business, Missfresh filed a late filing notice on Form 12b-25 with the SEC, noting, among other things, that the independent audit committee of the company’s board of directors acted with the assistance of professional advisers, “[wa]”s in the process of conducting an internal review of certain matters, including those related to transactions between the company and certain third-party companies.” Following the news, Missfresh ADSs fell 13%, closing at…
Continue to read on GlobeNewswire https://www.globenewswire.com/news-release/2022/09/12/2513621/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-Missfresh-Molecular-Partners-TG-Therapeutics-and-17EdTech-and-Encourages-Investors-to-C.html